pro-bono-bio

Médias

Pro Bono Bio Announces the Successful Development of Subcutaneous and Long-Acting Blood Factors VIIa,VIII and IX for the Treatment of Haemophilia

Médias

Malaysian Approval of FLEXISEQ™ and Distribution Agreement